<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
UNIVERSAL HEALTH SERVICES, INC.
----------------------------------------------------------------
(Name of Issuer)
Class B Common Stock, $.01 Par Value
----------------------------------------------------------------
(Title of Class of Securities)
913903100
-----------------------------
(CUSIP Number)
Stephen M. Vine, Esq.
Akin, Gump, Strauss, Hauer & Feld, L.L.P.
65 East 55th Street, 33rd Floor
New York, New York 10022
(212) 872-1000
-----------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 15, 1994
---------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7)
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosure provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Continued on following page(s)
Page 1 of 5 Pages
Exhibit Index: None
<PAGE> 2
SCHEDULE 13D
<TABLE>
<CAPTION>
CUSIP NO. 913903100 PAGE 2 OF 5 PAGES
<S> <C> <C>
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
GEORGE SOROS (doing business as SOROS FUND MANAGEMENT)
2 Check the Appropriate Box If a Member of a Group*
a. / /
b. / /
3 SEC Use Only
4 Source of Funds*
AF
5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) / /
6 Citizenship or Place of Organization
UNITED STATES
7 Sole Voting Power
Number of 650,000
Shares
Beneficially 8 Shared Voting Power
Owned By 0
Each
Reporting 9 Sole Dispositive Power
Person 650,000
With
10 Shared Dispositive Power
0
11 Aggregate Amount Beneficially Owned by Each Reporting Person
650,000
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* / /
13 Percent of Class Represented By Amount in Row (11)
4.98%
14 Type of Reporting Person*
IA; IN
</TABLE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
Page 3
This Amendment No.3 to Schedule 13D relates to shares (the "Shares")
of Class B Common Stock, $.01 par value, of Universal Health Services, Inc.
(the "Issuer"). This statement on Schedule 13D is being filed by the Reporting
Person to report a recent disposition of Shares as a result of which the
Reporting Person became the beneficial owner of less than 5% of the outstanding
Shares. This statement on Schedule 13D amends the initial statement on
Schedule 13D filed by the Reporting Person on May 19, 1994, as amended by
Amendment No. 1 on June 29, 1994 and by Amendment No. 2 on October 27, 1994
(collectively, the "Initial Statement"). Reference is made to the Initial
Statement for information concerning certain defined terms used herein but not
otherwise defined herein.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) The Reporting Person may be deemed the beneficial
owner of 650,000 Shares (approximately 4.98% of the total number of Shares
outstanding). This number consists of (i) 342,300 Shares held for the account
of Quantum Partners (approximately 2.62% of the total number of Shares
outstanding) and (ii) 307,700 Shares held for the account of Quasar Partners
(approximately 2.36% of the total number of Shares outstanding). Mr. Soros, as
sole proprietor of SFM, may be considered a beneficial owner of the Shares held
for the account of the SFM Clients by reason of the SFM Contracts with the SFM
Clients for the purposes of Section 13(d) of the 1934 Act.
(c) A schedule identifying all transactions involving the
Shares effected by the Reporting Person since October 27, 1994 (the date of the
most recent filing on Schedule 13D) is included as Annex A hereto which is
incorporated by reference in response to this Item 5(c). Each of the
transactions was executed in conventional brokerage transactions in the
over-the-counter market. Except for the transactions listed in Annex A, there
have been no transactions with respect to the Shares since October 27, 1994, by
the Reporting Person or other persons identified in response to Item 2.
(e) The Reporting Person ceased to be the beneficial
owner of five percent or more of the outstanding Shares on November 15, 1994.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
(a) Power of Attorney, dated December 11, 1991, granted
by Mr. George Soros in favor of Mr. Sean C. Warren (filed as Exhibit A to the
Initial Statement and incorporated herein by reference).
<PAGE> 4
Page 4
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Date: November 16, 1994 GEORGE SOROS
By: /s/ Sean C. Warren
---------------------------
Sean C. Warren
Attorney-in-Fact
<PAGE> 5
Page 5
ANNEX A
RECENT TRANSACTIONS IN COMMON STOCK OF UNIVERSAL HEALTH SERVICES, INC.
<TABLE>
<CAPTION>
For the Account of Date of Transaction Nature of Transaction Number of Shares Price per Share($)
- ----------------------- ----------------------- ------------------------- -------------------- ----------------------
<S> <C> <C> <C> <C>
Quasar International 11/10/94 Purchase 3,100 26.050
Partners C.V.(1) 11/15/94 Sale 62,800 25.375
</TABLE>
<TABLE>
<CAPTION>
For the Account of Date of Transaction Nature of Transaction Number of Shares Price per Share($)
- ----------------------- ----------------------- ------------------------- -------------------- ----------------------
<S> <C> <C> <C> <C>
Quantum Partners LDC(1) 11/10/94 Purchase 4,200 26.050
11/15/94 Sale 69,600 25.375
</TABLE>
- ------------------------
(1) Transactions effected at the direction of Soros Fund Management
